Biomarin Pharmaceutical Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$1,024,646	$989,708	$766,208	$874,565
Gross Profit	819,230	786,913	571,209	579,470
EBITDA	54,324	222,317	172,572	-3,937
EBIT	-76,141	124,679	156,161	-24,375
Net Income	-122,831	44,762	105,527	-46,573
Net Change In Cash	1,024,646	989,708	766,208	874,565
Free Cash Flow	159,921	139,293	199,728	58,922
Cash	736,007	874,005	2,222,435	1,311,679
Basic Shares	193,590	194,147	197,671	197,394

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$3,221,253	$2,853,915	$2,419,226	$2,096,039
Gross Profit	2,484,425	2,273,680	1,887,164	1,593,016
EBITDA	572,936	650,528	306,773	265,359
EBIT	493,379	554,102	202,387	163,390
Net Income	348,901	426,859	167,645	141,561
Net Change In Cash	3,221,253	2,853,915	2,419,226	2,096,039
Free Cash Flow	724,956	475,423	51,648	54,943
Cash	1,311,679	942,842	755,127	724,531
Basic Shares	197,394	196,708	191,595	188,963